Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population
Aminoglycoside dosing has been studied in the obese population, typically recommending an adjusted weight utilizing a 40% dosing weight correction factor (IBW + 0.4 × (TBW–IBW)). These studies included limited numbers of morbidly obese patients and were not done in the era of extended interval amino...
Saved in:
Main Authors: | Ashley L. Ross, Jennifer L. Tharp, Gerald R. Hobbs, Richard McKnight, Aaron Cumpston |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Advances in Pharmacological Sciences |
Online Access: | http://dx.doi.org/10.1155/2013/194389 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Once-Daily Dosing of Aminoglycosides
by: William A Craig
Published: (1994-01-01) -
Extended-Interval Gentamicin Dosing for Pulmonic Tularemia
by: Tyson Dietrich, et al.
Published: (2019-01-01) -
High Level Aminoglycoside Resistance and Distribution of Aminoglycoside Resistant Genes among Clinical Isolates of Enterococcus Species in Chennai, India
by: Elango Padmasini, et al.
Published: (2014-01-01) -
Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient
by: Lee A. Hugar, et al.
Published: (2016-01-01) -
Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics
by: Regina Stoltenburg, et al.
Published: (2012-01-01)